[Tirzepatide] is in a class of its own as the only FDA-approved dual GIP and GLP-1 receptor agonist obesity medication, and it's changing how millions of people manage this chronic disease, Glass added
In this article, the term refers to dosing strategies below the initiation levels used in large clinical trials (see Key Definitions below)
This is one reason some clinical investigators trialed hexarelin specifically as a diagnostic tool rather than a chronic therapeutic
Problems often go unreported
For injection-to-tablet switch (Wegovy Injection/Mounjaro Injection Wegovy Tablets) The published guidance follows the same logic: take the final injection as normal, wait seven days, then start the tablet on what would have been the next scheduled injection day
However, drinking coffee may increase your risk of gastrointestinal side effects